Top Markets
Coin of the day
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

ARMP
Rangering i aksjer #18294
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology... Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
Aksjekurs
$5.59
Sist synkronisert: 2026-09-02
Markedsverdi
$205.21M
Endring (1 dag)
6.27%
Endring (1 år)
86.33%
Land
US
Handel Armata Pharmaceuticals, Inc. (ARMP)

Kategori

Aksjeprishistorikk for Armata Pharmaceuticals, Inc. (ARMP)
Høyeste sluttskurs: $5.43 den 2026-09-01

Laveste sluttskurs: $435.94K den 1994-05-01
Aksjeprishistorikk for Armata Pharmaceuticals, Inc. fra 1994 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 13.52%
2025 190.05%
2024 -19.95%
2023 58.46%
2022 -67.90%
2021 72.26%
2020 -23.93%
2019 34.77%
2018 -79.83%
2017 -78.80%
2016 -90.19%
2015 -42.27%
2014 -62.10%
2013 143.79%
2012 51.63%
2011 -68.50%
2010 43.56%
2009 25.27%
2008 -87.80%
2007 -70.87%
2006 15.56%
2005 -67.75%
2004 -29.84%
2003 404.64%
2002 -82.93%
2001 -65.33%
2000 120.04%
1999 124.66%
1998 -44.75%
1997 -28.14%
1996 -25.02%
1995 26.21%
1994 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$123.05 -8.95%
AU
$757.71 6.76%
CH